SUN Pharmaceutical Industries Limited Pantoprazole Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Pantoprazole Export Records India — #4 Exporter, 776 Shipments, $31.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Pantoprazole

India Pharmaceutical Trade Intelligence

$1.3B744 Suppliers154 CountriesHS 30049039

ExportsIndia → UNITED STATES68.3%India → MALTA12.6%

ImportsGERMANY → India$152.4K BRAZIL → India$68.7K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

SUN Pharmaceutical Industries Limited — Pantoprazole Exporter #4 | $31.0M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Pantoprazole Exporter Profile

Indian Pharmaceutical Exporter · #4 for Pantoprazole · $31.0M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #4 Indian exporter of Pantoprazole with $31.0M in export value and 776 verified shipments. SUN Pharmaceutical Industries Limited holds a 2.3% market share in Pantoprazole exports across 19 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Pantoprazole Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Pantoprazole export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Pantoprazole?

Country	Value	Shipments	Share
BELGIUM	$13.9M	535	64.3%
SOUTH AFRICA	$1.5M	43	6.8%
AUSTRALIA	$856.9K	21	4.0%
HONG KONG	$734.8K	22	3.4%

Who Are the Top Buyers of Pantoprazole from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$13.5M	523
RANBAXY PHARMACEUTICALS PTY(LTD)	SOUTH AFRICA	$561.4K	18
SUN PHARMA ANZ PTY LTD	AUSTRALIA	$548.3K	11
SUN FARMACEUTICA DO BRAZIL LTDA	BRAZIL	$423.4K	10
RANBAXY PHARMACEUTICALS PTY LIMITED	SOUTH AFRICA	$331.3K	7
MYIT MAHAR TRADING CO., LTD.	MYANMAR	$279.9K	15
HAPHARCO J.S.C BRANCH	VIETNAM, DEMOCRATIC REP. OF	$268.5K	8
SUN PHARMACEUTICAL INDUSTRIES,INC.	UNITED STATES	$250.1K	9
RANBAXY PHARMACEUTICALS PTY LTD	SOUTH AFRICA	$235.1K	10
TO HONG KONG MEDICAL SUPPLIES LTD.	HONG KONG	$203.5K	7

SUN Pharmaceutical Industries Limited supplies Pantoprazole to 81 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by RANBAXY PHARMACEUTICALS PTY(LTD) (SOUTH AFRICA) and SUN PHARMA ANZ PTY LTD (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Pantoprazole Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
PANTOPRAZOL GASTRO-RESISTANT TABLETS 40MG ( PANTOPRAZOL BASICS TAB 40MG ) EACH TABLET CONTAINS: PANTOPRAZOLE SODIUM SESQ	$1.7M	77
PANTOPRAZOLE GASTRO-RESISTANT TABLETS 20	$1.3M	44
PANTOPRAZOLE GASTRO-RESISTANT TABLETS 20MG ( PANTOPRAZOL BASICS TAB 20MG ) EACHTABLET CONTAINS: PANTOPRAZOLE SODIUM SES	$714.8K	26
PANTOPRAZOL GASTRO-RESISTANT TABLETS 40MG PANTOPRAZOL BASICS TAB 40MG EACH TABLET CONTAINS: PANTOPRAZOLE SODIUM SESQ	$652.5K	18
PANTOPRAZOL GASTRO-RESISTANT TABLETS 40MG ( PANTOPRAZOL BASICS TAB 40MG ) EACH TABLET CONTAINS: PANTOPRAZOLE SODIUM SESQPCS	$447.8K	41
PANTOPRAZOLE GASTRO-RESISTANT TABLETS 40MG ( PANTOPRAZOL BASICS TAB 40MG ) EACHTABLET CONTAINS: PANTOPRAZOLE SODIUM SES	$367.1K	17
PANTASUN I.V INJ (PANTOPRAZOLE) (PACK:01	$323.4K	7
PANTOPRAZOLE 40 MG INJ 10X10 ML VIAL AUS	$294.7K	6
PANTOPRAZOLE GASTRO-RESISTANT TABLETS 40	$282.4K	11
PANTOPRAZOLE POWDER FOR SOLUTION FOR INJ	$280.9K	6

SUN Pharmaceutical Industries Limited exports 333 distinct Pantoprazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PANTOPRAZOL GASTRO-RESISTANT TABLETS 40MG ( PANTOPRAZOL BASI with 77 shipments worth $1.7M.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Pantoprazole Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	AUROBINDO PHARMA LTD	$67.8M	1,356	13	$50.0K
1	MYLAN LABORATORIES LIMITED	$33.0M	661	10	$50.0K
4	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$31.0M	776	19	$40.0K
5	TORRENT PHARMACEUTICALS LTD	$19.7M	509	23	$38.8K
6	IPCA LABORATORIES LIMITED	$16.2M	420	13	$38.5K

SUN Pharmaceutical Industries Limited ranks #4 among 744 Indian Pantoprazole exporters. Average shipment value of $40.0K compared to the market average of $310.5K. The closest competitors by value are AUROBINDO PHARMA LTD and MYLAN LABORATORIES LIMITED.

Which Indian Ports Ship Pantoprazole Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	1,075	9.3%
SAHAR AIR	926	8.0%
SAHAR AIR CARGO ACC (INBOM4)	821	7.1%
JNPT/ NHAVA SHEVA SEA	652	5.6%
JNPT	463	4.0%
VIZAG SEA	455	3.9%
HYDERABAD AIR	435	3.7%
DELHI AIR CARGO ACC (INDEL4)	427	3.7%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Pantoprazole Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Pantoprazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 802 individual customs records matching SUN Pharmaceutical Industries Limited exporting Pantoprazole, covering 333 formulations to 23 countries via 81 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 154+ countries, 1,893+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Pantoprazole

Pantoprazole

SUN Pharmaceutical Industries Limited — Pantoprazole Exporter Profile

SUN Pharmaceutical Industries Limited — Pantoprazole Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Pantoprazole?

Who Are the Top Buyers of Pantoprazole from SUN Pharmaceutical Industries Limited?

What Is India's Total Pantoprazole Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Pantoprazole Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Pantoprazole Exporters?

What Pantoprazole Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Pantoprazole to Key Markets

South Africa — SAHPRA

Australia — TGA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Pantoprazole Exporters?

Which Indian Ports Ship Pantoprazole Exports?

What Other Gastrointestinal Products Does SUN Pharmaceutical Industries Limited Export?

Pantoprazole — Export Intelligence Video

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Pantoprazole Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Pantoprazole Export Data from SUN Pharmaceutical Industries Limited

Pantoprazole Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source